☆ 4.6 Article

Performance of Existing and Novel Symptom- and Antigen Testing-Based COVID-19 Case Definitions in a Community Setting

AMERICAN JOURNAL OF EPIDEMIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Public, Environmental & Occupational Health

Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees

Allison E. James et al.

Summary: The sensitivity of the BinaxNOW test among asymptomatic healthcare employees is relatively low compared to rRT-PCR, but it can facilitate rapid detection and isolation of infected individuals in certain settings while awaiting rRT-PCR results.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Add to Collection

Article Microbiology

Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020

Olivia Almendares et al.

Summary: Point-of-care antigen tests are important for SARS-CoV-2 detection, offering quicker turnaround time compared to laboratory-based nucleic acid amplification tests. However, their sensitivity is limited, especially among individuals with known exposure.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

Add to Collection

Article Immunology

Field Performance and Public Health Response Using the BinaxNOW™ Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing

Genay Pilarowski et al.

Summary: The study conducted testing for SARS-CoV-2 among 3302 individuals in a community setting using BinaxNOW(TM) and reverse transcription polymerase chain reaction (RT-PCR). The rapid assay showed high sensitivity and specificity, with consistent performance across different age groups and symptomatic status, allowing for immediate public health action.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Performance of existing and novel surveillance case definitions for COVID-19 in household contacts of PCR-confirmed COVID-19

Hannah E. Reses et al.

Summary: The study evaluated the diagnostic performance of COVID-19 case definitions for household contacts, finding existing definitions to have high sensitivity but low positive predictive value, with new symptom combinations including taste or smell dysfunction showing potential for improved accuracy, and performance indicators generally lower for children.

BMC PUBLIC HEALTH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020

Jessica L. Prince-Guerra et al.

Summary: The study indicates that the sensitivity of BinaxNOW antigen test is lower in asymptomatic individuals, but with high specificity. Additionally, some antigen test-negative specimens still contained culturable virus.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Microbiology

Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts

Nira R. Pollock et al.

Summary: The study evaluated the performance of the Abbott BinaxNOW COVID-19 Ag card in a community testing site and found high sensitivity in newly symptomatic adults, but lower sensitivity in children and asymptomatic individuals, revealing potential limitations of the BinaxNOW test.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Microbiology

Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting

Nkemakonam C. Okoye et al.

Summary: The performance of Abbott BinaxNOW COVID-19 antigen card was compared to a standard RT-PCR assay for detecting SARS-CoV-2 in asymptomatic students. Results showed lower sensitivity but higher specificity for BinaxNOW compared to RT-PCR, indicating caution is needed when using rapid antigen testing for screening asymptomatic individuals.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Infectious Diseases

Scaling up COVID-19 rapid antigen tests: promises and challenges

Rosanna W. Peeling et al.

Summary: WHO recommends antigen-detection rapid diagnostic tests (Ag-RDTs) with at least 80% sensitivity and 97% specificity for patients with symptoms consistent with COVID-19. Ag-RDTs may show high false negative rates after the acute phase, suggesting the need for a combination of molecular and serological tests. In low prevalence settings and situations where infection needs to be ruled out, Ag-RDTs with high negative predictive values can be used confidently, but high false positive rates in low prevalence areas require further confirmation.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak

Susannah L. McKay et al.

Summary: This study evaluated the performance of SARS-CoV-2 antigen testing during a nursing home outbreak, with the BinaxNOW test showing a positive agreement of 95% with virus culture. Antigen testing had a positive agreement of 52% with RT-PCR in asymptomatic individuals, performing poorly in late infection (51%).

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Immunology

Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020-December 2020

Melisa M. Shah et al.

Summary: Repeat BinaxNOW antigen testing using 2 groups of readers within 30 minutes showed high concordance (98.9%) in 2110 encounters, with same-day repeat tests not significantly improving sensitivity (77.2% to 81.4%), while maintaining high specificity (99.6%).

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing

Laura Ford et al.

Summary: The study found that the sensitivity of SARS-CoV-2 antigen testing was 78.9% among symptomatic participants and 43.8% among asymptomatic participants. Negative antigen results were more likely among asymptomatic participants, while nasal congestion symptoms were associated with a positive antigen result.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting

Neeraj Sood et al.

Summary: Rapid antigen testing shows promise in identifying COVID infections in children, especially those with symptoms, and is negatively associated with Ct values.

PLOS ONE (2021)

Add to Collection

Article Microbiology

A Real-World Comparison of SARS-CoV-2 Rapid Antigen Testing versus PCR Testing in Florida

Lao-Tzu Allan-Blitz et al.

Summary: The positive percent agreement (PPA) of Abbott BinaxNOW COVID-19 Ag card compared to PCR was lower than previously reported, but showed a slight improvement in individuals with symptomatic presentation and a better performance in individuals with lower cycle threshold values.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration

Jennifer K. Frediani et al.

Summary: Though there has been progress in rapid COVID-19 testing technology, challenges remain in accurately detecting viral variants and implementing self-testing at home. Research indicates that BinaxNOW can detect various new variants, but sensitivity may decrease due to user error.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Immunology

Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA

Krishna Surasi et al.

Summary: The Abbott BinaxNOW rapid antigen test showed high negative agreement and positive predictive value in screening for COVID-19, making it a valuable tool for rapid screening. Additionally, compared to rRT-PCR, BinaxNOW detected lower cycle thresholds in positive samples, allowing for quicker identification of infected individuals.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

Tim Peto

Summary: The study found that four LFDs have desirable performance characteristics in viral antigen detection, with Innova LFD showing good sensitivity and specificity. The potential issues of kit failure rates and training impact were noted. LFDs can be used for mass population testing to identify infectious individuals.

ECLINICALMEDICINE (2021)

Add to Collection

Article Biochemical Research Methods

SciPy 1.0: fundamental algorithms for scientific computing in Python

Pauli Virtanen et al.

NATURE METHODS (2020)

Add to Collection

Article Computer Science, Artificial Intelligence

Supersparse linear integer models for optimized medical scoring systems

Berk Ustun et al.

MACHINE LEARNING (2016)

Add to Collection

Article Medicine, General & Internal

An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV

Kevin P. Cain et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Add to Collection

Article Computer Science, Artificial Intelligence

Random forests

L Breiman

MACHINE LEARNING (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.